Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
NOVARTIND Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Moderate ROE but improving trend
High and improving operating margin
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Low revenue growth and lower than median growth of industry
Neutral
Company's earnings are of moderate quality
Moderate dividend yield
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
NOVARTIND Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
NOVARTIND Bulk, Block & Insider Trades
NOVARTIND Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Others
Share Buyback"On Market Tender Offer. Total amount Returned INR 2311500000 and Share capital 12.26percent currently. Offer Price INR 670." Ex-date: 7th Dec 2017 Announced on: 25th Sep 2017
MergerEquity shares alloted to the erstwhile shareholders of Ciba CKD Biochem Ltd. as per the scheme of amalgamation with the company. Ex-date: 31st Mar 2001 Announced on: 31st Mar 2001
Demerger (DEM)Demerger of Ciba speciality Chemicals (CSC) from Hind Ciby Geigy. Shareholders will be allotted 5 shares of INR 0.10 each of CSC for 1 share of INR 1.0 held by them in HCG. Ex-date: 29th Dec 1997 Announced on: 8th Oct 1997
Company Profile
Novartis India Limited is an India-based company. The Company is primarily engaged in the business of trading of Pharmaceuticals. It operates in the Pharmaceutical business segment. The Company’s brands hold key positions in therapeutic areas, such as, Voveran, which is the brand for bone and pain; ... Read More
Key personnel
Mr. Christopher SnookD
Non-Executive Non-Independent Chairman of the Board
Ms. Shilpa JoshiD
Chief Financial Officer, Whole-Time Director
Ms. Chandni Maru
Chief Compliance Officer, Company Secretary
Mr. Falin Ishwarlal MajmudarD
Additional Director (Whole-Time Director)
Ms. Sandra MartryesD
Non-Executive Independent Director
Mr. Sanker ParameswaranD
Non-Executive Independent Director
Ms. Gira SardesaiD
Additional Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Novartis India Ltd.?
The current share price of Novartis India Ltd. is ₹ 800.05 as of 09 Jan 2026.
What is the PE ratio of Novartis India Ltd.?
The Price-to-Earnings (PE) ratio of Novartis India Ltd. is 18.53 as of the latest financial data.
What is the ROE and ROCE of Novartis India Ltd.?
Novartis India Ltd. has a Return on Equity (ROE) of 14.17% and a Return on Capital Employed (ROCE) of 13.01% as per the latest financial reports.
What is the market cap of Novartis India Ltd.?
The market capitalization of Novartis India Ltd. stands at ₹ 1,975.40 Cr.
What is the dividend yield of Novartis India Ltd.?
The dividend yield of Novartis India Ltd. is 3.12% based on the current market price.
What is the RSI of Novartis India Ltd.?
The Relative Strength Index (RSI) of Novartis India Ltd. is 54.07.
What is the FII and DII holding in Novartis India Ltd.?
Foreign Institutional Investors (FII) hold 0.19% and Domestic Institutional Investors (DII) hold 0.52% of Novartis India Ltd. shares.
What sector does Novartis India Ltd. belong to?
Novartis India Ltd. operates in the Healthcare sector.
What is the beta of Novartis India Ltd. stock?
The beta of Novartis India Ltd. stock is 0.54, indicating its volatility relative to the broader market.
